Tonix Pharmaceuticals Hol...
(TNXP)
undefined
undefined%
At close: undefined
0.31
-2.15%
Pre-market Jan 07, 2025, 05:17 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -116.66M | -110.22M | -92.29M | -50.46M | -28.62M | -26.09M | -21.12M | -38.84M | -48.05M | -27.62M | -10.88M | -9.45M | -3.47M | -17.72K | -30.87K | -21.13K |
| Depreciation & Amortization | 4.29M | 1.25M | 50.00K | 27.00K | 26.00K | 54.00K | 70.00K | 206.00K | 161.00K | 36.00K | 17.00K | 14.33K | 9.30K | n/a | n/a | n/a |
| Stock-Based Compensation | 9.28M | 10.91M | 7.90M | 2.88M | 1.46M | 1.63M | 1.79M | 3.27M | 4.39M | 3.09M | 1.72M | 865.16K | 435.65K | n/a | n/a | n/a |
| Other Working Capital | 3.39M | 1.04M | 2.25M | -3.89M | -1.21M | 331.00K | -289.00K | 107.00K | -607.00K | 316.00K | 642.00K | 135.93K | -43.21K | 425.00 | 2.01K | -2.43K |
| Other Non-Cash Items | 1.12M | 14.46M | 3.00M | 1.36M | -154.00K | 1.63M | 1.50M | 133.00K | 3.06M | 608.00K | 51.00K | 1.41M | 53.38K | n/a | n/a | n/a |
| Deferred Income Tax | n/a | -14.46M | n/a | n/a | 154.00K | n/a | n/a | n/a | n/a | n/a | n/a | 1.18M | n/a | n/a | n/a | n/a |
| Change in Working Capital | -35.00K | -2.00K | 5.78M | -2.37M | 452.00K | 437.00K | 135.00K | -2.08M | 976.00K | 1.04M | 582.00K | 266.57K | 334.25K | -258 | 3.00K | -2.43K |
| Operating Cash Flow | -102.00M | -98.05M | -75.56M | -48.57M | -26.68M | -23.97M | -19.13M | -37.31M | -42.53M | -22.84M | -8.52M | -5.71M | -2.64M | -17.98K | -27.87K | -23.57K |
| Capital Expenditures | -7.89M | -48.15M | -35.31M | -8.56M | -17.00K | -6.00K | -5.00K | -66.00K | -238.00K | -319.00K | -15.00K | -35.67K | -2.76K | n/a | n/a | n/a |
| Acquisitions | -22.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 120.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 7.17M | 16.61M | 4.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 999.00K | n/a | n/a | n/a | -17.00K | -6.00K | 7.17M | 45.00K | -120.00K | -73.00K | -15.00K | -90 | 3.07K | n/a | n/a | n/a |
| Investing Cash Flow | -29.07M | -48.15M | -35.31M | -8.56M | -17.00K | -6.00K | 7.17M | 16.59M | -24.17M | -392.00K | -15.00K | -35.76K | 302.00 | n/a | n/a | n/a |
| Debt Repayment | 8.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 280.00K | 560.00K | 2.00M | 50.00K | n/a | n/a |
| Common Stock Repurchased | -13.96M | -47.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | -6.66M | n/a | -451.00K | -2.47M | -3.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 22.60M | 40.00K | 98.00K | 14.95M | 9.55M | 14.09M | 14.00K | n/a | 9.00K | 53.22M | 14.67M | -106 | n/a | 1.34M | n/a | n/a |
| Financial Cash Flow | 36.52M | 87.84M | 212.49M | 123.11M | 12.92M | 23.54M | 18.52M | 20.50M | 47.69M | 53.22M | 14.95M | 7.49M | 2.61M | 10.00K | n/a | 50.00K |
| Net Cash Flow | -94.62M | -58.43M | 101.59M | 65.96M | -13.79M | -451.00K | 6.55M | -234.00K | -19.01M | 29.98M | 6.42M | 1.74M | -24.24K | -7.98K | -27.87K | 26.43K |
| Free Cash Flow | -109.90M | -146.20M | -110.86M | -57.13M | -26.70M | -23.98M | -19.13M | -37.38M | -42.77M | -23.16M | -8.53M | -5.75M | -2.64M | -17.98K | -27.87K | -23.57K |